Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;126(3):306-308.
doi: 10.1016/j.anai.2020.12.014. Epub 2020 Dec 30.

Monitoring neutrophil-to-lymphocyte ratio in patients with coronavirus disease 2019 receiving tocilizumab

Affiliations

Monitoring neutrophil-to-lymphocyte ratio in patients with coronavirus disease 2019 receiving tocilizumab

Nicholas L Hartog et al. Ann Allergy Asthma Immunol. 2021 Mar.
No abstract available

PubMed Disclaimer

References

    1. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. - PMC - PubMed
    1. Mehta P., McAuley D.F., Brown M. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. - PMC - PubMed
    1. Hwang S.Y., Shin T.G., Jo I.J. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically ill septic patients. Am J Emerg Med. 2017;35(2):234–239. - PubMed
    1. Liu J., Liu Y., Xiang P. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):206. - PMC - PubMed
    1. Morrissey S.M., Geller A.E., Hu X. Emergence of low-density inflammatory neutrophils correlates with hypercoagulable state and disease severity in COVID-19 patients. https://www.medrxiv.org/content/10.1101/2020.05.22.20106724v1 - DOI

MeSH terms